Neurocrine Biosciences, Inc. (NBIX)
128.32
-0.31
(-0.24%)
USD |
NASDAQ |
Feb 23, 16:00
128.32
0.00 (0.00%)
After-Hours: 18:46
Neurocrine Biosciences Market Cap : 12.88B for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Glaukos Corp. | 6.916B |
| Edgewise Therapeutics, Inc. | 3.187B |
| Nuvalent, Inc. | 7.495B |
| Marker Therapeutics, Inc. | 24.34M |
| CapsoVision, Inc. | 252.02M |
Market Cap Related Metrics
| PE Ratio | 27.49 |
| PS Ratio | 4.595 |
| PEG Ratio | 0.6572 |
| Price to Book Value | 3.959 |
| Price to Free Cash Flow | 17.55 |
| Price | 128.32 |
| Earnings Yield | 3.64% |
| PEGY Ratio | 0.6572 |
| Operating PE Ratio | 20.65 |
| Normalized PE Ratio | 26.66 |